The article is mostly about a couple of recent WHO pronouncements about treatment of covid19 patients:
Don't use Remdesivir (!!?!)
Don't use plasma therapy (except in a trial)
Dhaka Medical College Hospital brought attention to plasma therapy when it started a trial.
This seems important:
It also suggested doctors in areas with other endemic infections that cause fever such as malaria, and dengue, “febrile patients should be tested and treated for those endemic infections per routine protocols, irrespective of the presence of respiratory signs and symptoms. Co-infection with COVID-19 may occur.”
It happens that ivermectin is active against and dengue. "Febrile" = having or showing the symptoms of a fever.
The new clinical guideline for doctors was developed by a multidisciplinary panel of health care providers with experience in the clinical management of patients with COVID-19 and other viral infections, including severe acute respiratory virus (SARS) and Middle East respiratory virus (MERS), as well as sepsis and acute respiratory distress syndrome (ARDS).
Ivermectin is also constrained by the rules about what treatment can be applied outside of a clinical trial.
Prof Meerjady Sabrina Flora, director of the government’s disease monitoring agency IEDCR, told Bangladesh Post they did not recommend any of those drugs to patients for treatment.
She is also the member secretary of the national technical advisory committee on Covid-19.
“The IEDCR made it clear before that those can be used as trials, not for confirmed treatment. And doctors who will conduct those trials will take consent from patients and then it’s up to patient whether they want to take part or not,” she said.
“But it’s not that you’ll use it (antivirals or plasma therapy) invariably for all patients. Still there is no specific treatment,” she said.
“Anybody wants to conduct trails of drug, they will have to take approval from the national review committee,” she said.
“It’s true for all drugs,” she said, when asked about the ivermectin which a doctor in Bangladesh claimed to be useful for coronavirus patients in combination with another drug.
This surprises me:
On plasma therapy, Prof Flora said, they don’t suggest plasma therapy since it is still not sure whether antibody develops or not in Covid-19 patients.
[-] TrumpLyftAlles | 2 points | May 31 2020 13:09:37
The article is mostly about a couple of recent WHO pronouncements about treatment of covid19 patients:
Dhaka Medical College Hospital brought attention to plasma therapy when it started a trial.
This seems important:
It also suggested doctors in areas with other endemic infections that cause fever such as malaria, and dengue, “febrile patients should be tested and treated for those endemic infections per routine protocols, irrespective of the presence of respiratory signs and symptoms. Co-infection with COVID-19 may occur.”
It happens that ivermectin is active against and dengue. "Febrile" = having or showing the symptoms of a fever.
The new clinical guideline for doctors was developed by a multidisciplinary panel of health care providers with experience in the clinical management of patients with COVID-19 and other viral infections, including severe acute respiratory virus (SARS) and Middle East respiratory virus (MERS), as well as sepsis and acute respiratory distress syndrome (ARDS).
Ivermectin is also constrained by the rules about what treatment can be applied outside of a clinical trial.
Prof Meerjady Sabrina Flora, director of the government’s disease monitoring agency IEDCR, told Bangladesh Post they did not recommend any of those drugs to patients for treatment.
She is also the member secretary of the national technical advisory committee on Covid-19.
“The IEDCR made it clear before that those can be used as trials, not for confirmed treatment. And doctors who will conduct those trials will take consent from patients and then it’s up to patient whether they want to take part or not,” she said.
“But it’s not that you’ll use it (antivirals or plasma therapy) invariably for all patients. Still there is no specific treatment,” she said.
“Anybody wants to conduct trails of drug, they will have to take approval from the national review committee,” she said.
“It’s true for all drugs,” she said, when asked about the ivermectin which a doctor in Bangladesh claimed to be useful for coronavirus patients in combination with another drug.
This surprises me:
On plasma therapy, Prof Flora said, they don’t suggest plasma therapy since it is still not sure whether antibody develops or not in Covid-19 patients.
Really. I think that is known?!!
permalink